{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:50:41Z","timestamp":1768366241395,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172738, 82473356"],"award-info":[{"award-number":["82172738, 82473356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172738, 82473356"],"award-info":[{"award-number":["82172738, 82473356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172738, 82473356"],"award-info":[{"award-number":["82172738, 82473356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172738, 82473356"],"award-info":[{"award-number":["82172738, 82473356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172738, 82473356"],"award-info":[{"award-number":["82172738, 82473356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["23Y31900202"],"award-info":[{"award-number":["23Y31900202"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["23Y31900202"],"award-info":[{"award-number":["23Y31900202"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["23Y31900202"],"award-info":[{"award-number":["23Y31900202"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["23Y31900202"],"award-info":[{"award-number":["23Y31900202"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["23Y31900202"],"award-info":[{"award-number":["23Y31900202"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Health Commission Clinical Research Special Project","award":["202140140"],"award-info":[{"award-number":["202140140"]}]},{"name":"Shanghai Municipal Health Commission Clinical Research Special Project","award":["202140140"],"award-info":[{"award-number":["202140140"]}]},{"name":"Shanghai Municipal Health Commission Clinical Research Special Project","award":["202140140"],"award-info":[{"award-number":["202140140"]}]},{"name":"Shanghai Municipal Health Commission Clinical Research Special Project","award":["202140140"],"award-info":[{"award-number":["202140140"]}]},{"name":"Shanghai Municipal Health Commission Clinical Research Special Project","award":["202140140"],"award-info":[{"award-number":["202140140"]}]},{"name":"Shanghai Municipal Central Guided Local Science and Technology Development Fund Project","award":["YDZX20253100002003"],"award-info":[{"award-number":["YDZX20253100002003"]}]},{"name":"Shanghai Municipal Central Guided Local Science and Technology Development Fund Project","award":["YDZX20253100002003"],"award-info":[{"award-number":["YDZX20253100002003"]}]},{"name":"Shanghai Municipal Central Guided Local Science and Technology Development Fund Project","award":["YDZX20253100002003"],"award-info":[{"award-number":["YDZX20253100002003"]}]},{"name":"Shanghai Municipal Central Guided Local Science and Technology Development Fund Project","award":["YDZX20253100002003"],"award-info":[{"award-number":["YDZX20253100002003"]}]},{"name":"Shanghai Municipal Central Guided Local Science and Technology Development Fund Project","award":["YDZX20253100002003"],"award-info":[{"award-number":["YDZX20253100002003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01992-6","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:46:35Z","timestamp":1765266395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of tumor microenvironment-based molecular subtypes in hepatocellular carcinoma patients undergoing surgery for spinal metastases: refining conventional scoring systems"],"prefix":"10.1007","volume":"26","author":[{"given":"Bing","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"6","key":"1992_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"issue":"1","key":"1992_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2022-327132","volume":"72","author":"R Hernaez","year":"2023","unstructured":"Hernaez R, Avila MA. Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono? Gut. 2023;72(1):7\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2022-327132.","journal-title":"Gut"},{"issue":"1","key":"1992_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","volume":"164","author":"PK Haber","year":"2023","unstructured":"Haber PK, Castet F, Torres-Martin M, Andreu-Oller C, Puigveh\u00ed M, Miho M, et al. Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. Gastroenterology. 2023;164(1):72-88.e18. https:\/\/doi.org\/10.1053\/j.gastro.2022.09.005.","journal-title":"Gastroenterology"},{"key":"1992_CR4","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2025.0746","author":"S Sidali","year":"2025","unstructured":"Sidali S, Campani C, An J, Shim JH, Nault JC. Tumor-based biomarkers and circulating tumor DNA for precision medicine in advanced hepatocellular carcinoma. Clin Mol Hepatol. 2025. https:\/\/doi.org\/10.3350\/cmh.2025.0746.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"1992_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12029-017-9998-6","volume":"48","author":"R Bhatia","year":"2017","unstructured":"Bhatia R, Ravulapati S, Befeler A, Dombrowski J, Gadani S, Poddar N. Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management-single-center experience. J Gastrointest Cancer. 2017;48(4):321\u20135. https:\/\/doi.org\/10.1007\/s12029-017-9998-6.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"1992_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.6004\/jnccn.2017.7024","volume":"16","author":"JJ Harding","year":"2018","unstructured":"Harding JJ, Abu-Zeinah G, Chou JF, Owen DH, Ly M, Lowery MA, et al. Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma. J Natl Compr Canc Netw. 2018;16(1):50\u20138. https:\/\/doi.org\/10.6004\/jnccn.2017.7024.","journal-title":"J Natl Compr Canc Netw"},{"key":"1992_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.12659\/msm.913470","volume":"25","author":"X Guo","year":"2019","unstructured":"Guo X, Xu Y, Wang X, Lin F, Wu H, Duan J, et al. Advanced hepatocellular carcinoma with bone metastases: prevalence, associated factors, and survival estimation. Med Sci Monit. 2019;25:1105\u201312. https:\/\/doi.org\/10.12659\/msm.913470.","journal-title":"Med Sci Monit"},{"issue":"3","key":"1992_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Cl\u00e9zardin","year":"2021","unstructured":"Cl\u00e9zardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101(3):797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019.","journal-title":"Physiol Rev"},{"issue":"1","key":"1992_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40122-021-00251-2","volume":"10","author":"Z Wang","year":"2021","unstructured":"Wang Z, Sun J, Sun Y, Gu Y, Xu Y, Zhao B, et al. Machine learning algorithm guiding local treatment decisions to reduce pain for lung cancer patients with bone metastases, a prospective cohort study. Pain Ther. 2021;10(1):619\u201333. https:\/\/doi.org\/10.1007\/s40122-021-00251-2.","journal-title":"Pain Ther"},{"issue":"9","key":"1992_CR10","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.spinee.2021.04.012","volume":"21","author":"DM Sciubba","year":"2021","unstructured":"Sciubba DM, Pennington Z, Colman MW, Goodwin CR, Laufer I, Patt JC, et al. Spinal metastases 2021: a review of the current state of the art and future directions. Spine J. 2021;21(9):1414\u201329. https:\/\/doi.org\/10.1016\/j.spinee.2021.04.012.","journal-title":"Spine J"},{"issue":"3","key":"1992_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.spinee.2015.11.033","volume":"16","author":"JW Bae","year":"2016","unstructured":"Bae JW, Gwak HS, Kim S, Joo J, Shin SH, Yoo H, et al. Percutaneous vertebroplasty for patients with metastatic compression fractures of the thoracolumbar spine: clinical and radiological factors affecting functional outcomes. Spine J. 2016;16(3):355\u201364. https:\/\/doi.org\/10.1016\/j.spinee.2015.11.033.","journal-title":"Spine J"},{"issue":"5","key":"1992_CR12","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/os.70004","volume":"17","author":"HL Zheng","year":"2025","unstructured":"Zheng HL, Liu CH, Jiang LS, Zheng XF, Jiang SD. Unilateral dual-plane puncture percutaneous vertebroplasty reduces re-collapse in osteoporotic vertebral compression fractures by advancing cement delivery. Orthop Surg. 2025;17(5):1322\u201331. https:\/\/doi.org\/10.1111\/os.70004.","journal-title":"Orthop Surg"},{"issue":"12","key":"1992_CR13","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1016\/s1470-2045(17)30612-5","volume":"18","author":"DE Spratt","year":"2017","unstructured":"Spratt DE, Beeler WH, de Moraes FY, Rhines LD, Gemmete JJ, Chaudhary N, et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol. 2017;18(12):e720\u201330. https:\/\/doi.org\/10.1016\/s1470-2045(17)30612-5.","journal-title":"Lancet Oncol"},{"issue":"14","key":"1992_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/brs.0000000000004576","volume":"48","author":"Y Yan","year":"2023","unstructured":"Yan Y, Zhong G, Lai H, Huang C, Yao M, Zhou M, et al. Comparing the accuracy of seven scoring systems in predicting survival of lung cancer patients with spinal metastases: an external validation from two centers. Spine (Phila Pa 1976). 2023;48(14):1009\u201316. https:\/\/doi.org\/10.1097\/brs.0000000000004576.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1992_CR15","doi-asserted-by":"publisher","first-page":"394632025133397","DOI":"10.1177\/03946320251333975","volume":"39","author":"X Li","year":"2025","unstructured":"Li X, Qin Z, Chen H, Chen D, Alimu N, Li D, et al. Construction of a tumor immune microenvironment-related risk scoring model for prognosis of hepatocellular carcinoma. Int J Immunopathol Pharmacol. 2025;39:3946320251333975. https:\/\/doi.org\/10.1177\/03946320251333975.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"23","key":"1992_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416419","volume":"12","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhou B, Yang J, Ren C, Luo J, Li Z, et al. MTFR2-Mediated Fission Drives Fatty Acid and Mitochondrial Co-Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis. Adv Sci. 2025;12(23):e2416419. https:\/\/doi.org\/10.1002\/advs.202416419.","journal-title":"Adv Sci"},{"issue":"4","key":"1992_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3171\/2020.4.Spine20173","volume":"33","author":"E Massaad","year":"2020","unstructured":"Massaad E, Hadzipasic M, Alvarez-Breckenridge C, Kiapour A, Fatima N, Schwab JH, et al. Predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma: which scoring system is most accurate? J Neurosurg Spine. 2020;33(4):529\u201339. https:\/\/doi.org\/10.3171\/2020.4.Spine20173.","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"1992_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.spinee.2020.02.009","volume":"21","author":"AJ Schoenfeld","year":"2021","unstructured":"Schoenfeld AJ, Ferrone ML, Schwab JH, Blucher JA, Barton LB, Tobert DG, et al. Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score. Spine J. 2021;21(1):28\u201336. https:\/\/doi.org\/10.1016\/j.spinee.2020.02.009.","journal-title":"Spine J"},{"issue":"7","key":"1992_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/BRS.0b013e31822bd6b0","volume":"37","author":"M Wang","year":"2012","unstructured":"Wang M, B\u00fcnger CE, Li H, Wu C, H\u00f8y K, Niedermann B, et al. Predictive value of Tokuhashi scoring systems in spinal metastases, focusing on various primary tumor groups: evaluation of 448 patients in the Aarhus spinal metastases database. Spine (Phila Pa 1976). 2012;37(7):573\u201382. https:\/\/doi.org\/10.1097\/BRS.0b013e31822bd6b0.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"23","key":"1992_CR20","doi-asserted-by":"publisher","first-page":"E1339","DOI":"10.1097\/BRS.0b013e3181e574f5","volume":"35","author":"H Chen","year":"2010","unstructured":"Chen H, Xiao J, Yang X, Zhang F, Yuan W. Preoperative scoring systems and prognostic factors for patients with spinal metastases from hepatocellular carcinoma. Spine (Phila Pa 1976). 2010;35(23):E1339\u201346. https:\/\/doi.org\/10.1097\/BRS.0b013e3181e574f5.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"6","key":"1992_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/jco.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol. 2022;40(6):611\u201325. https:\/\/doi.org\/10.1200\/jco.21.01626.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1992_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101146","volume":"4","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhou K, Sun Z, Wang H, Xie J, Zhang T, et al. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics. Cell Rep Med. 2023;4(8):101146. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101146.","journal-title":"Cell Rep Med"},{"issue":"18","key":"1992_CR23","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1158\/0008-5472.Can-09-1089","volume":"69","author":"Y Hoshida","year":"2009","unstructured":"Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009;69(18):7385\u201392. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-1089.","journal-title":"Cancer Res"},{"issue":"1","key":"1992_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","volume":"72","author":"C Montironi","year":"2023","unstructured":"Montironi C, Castet F, Haber PK, Pinyol R, Torres-Martin M, Torrens L, et al. Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut. 2023;72(1):129\u201340. https:\/\/doi.org\/10.1136\/gutjnl-2021-325918.","journal-title":"Gut"},{"issue":"16","key":"1992_CR25","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1158\/0008-5472.Can-08-0742","volume":"68","author":"DY Chiang","year":"2008","unstructured":"Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, et al. <article-title update=\u201cadded\u201d> Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008;68(16):6779\u201388. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-0742.","journal-title":"Cancer Res"},{"issue":"2","key":"1992_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00262-024-03878-0","volume":"74","author":"CY Tang","year":"2025","unstructured":"Tang CY, Lin YT, Yeh YC, Chung SY, Chang YC, Hung YP, et al. The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer. Cancer Immunol Immunother. 2025;74(2):41. https:\/\/doi.org\/10.1007\/s00262-024-03878-0.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"1992_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/hep.0000000000000553","volume":"79","author":"B Li","year":"2024","unstructured":"Li B, Li Y, Zhou H, Xu Y, Cao Y, Cheng C, et al. Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma. Hepatology. 2024;79(2):289\u2013306. https:\/\/doi.org\/10.1097\/hep.0000000000000553.","journal-title":"Hepatology"},{"issue":"3","key":"1992_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","volume":"153","author":"D Sia","year":"2017","unstructured":"Sia D, Jiao Y, Martinez-Quetglas I, Kuchuk O, Villacorta-Martin C, Castro de Moura M, et al. Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features. Gastroenterology. 2017;153(3):812\u201326. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.007.","journal-title":"Gastroenterology"},{"issue":"10","key":"1992_CR29","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.spinee.2021.03.026","volume":"21","author":"AA Shah","year":"2021","unstructured":"Shah AA, Karhade AV, Park HY, Sheppard WL, Macyszyn LJ, Everson RG, et al. Updated external validation of the SORG machine learning algorithms for prediction of ninety-day and one-year mortality after surgery for spinal metastasis. Spine J. 2021;21(10):1679\u201386. https:\/\/doi.org\/10.1016\/j.spinee.2021.03.026.","journal-title":"Spine J"},{"issue":"11","key":"1992_CR30","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s00586-008-0763-1","volume":"17","author":"A Leithner","year":"2008","unstructured":"Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J. 2008;17(11):1488\u201395. https:\/\/doi.org\/10.1007\/s00586-008-0763-1.","journal-title":"Eur Spine J"},{"issue":"2","key":"1992_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/2192568217694016","volume":"7","author":"CL Tseng","year":"2017","unstructured":"Tseng CL, Eppinga W, Charest-Morin R, Soliman H, Myrehaug S, Maralani PJ, et al. Spine stereotactic body radiotherapy: indications, outcomes, and points of caution. Glob Spine J. 2017;7(2):179\u201397. https:\/\/doi.org\/10.1177\/2192568217694016.","journal-title":"Glob Spine J"},{"issue":"9","key":"1992_CR32","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.spinee.2021.05.001","volume":"21","author":"L Nguyen","year":"2021","unstructured":"Nguyen L, Agaronnik N, Ferrone ML, Katz JN, Schoenfeld AJ. Evaluating ambulatory function as an outcome following treatment for spinal metastases: a systematic review. Spine J. 2021;21(9):1430\u20139. https:\/\/doi.org\/10.1016\/j.spinee.2021.05.001.","journal-title":"Spine J"},{"issue":"5","key":"1992_CR33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1227\/neu.0000000000002989","volume":"95","author":"O Barzilai","year":"2024","unstructured":"Barzilai O, Sahgal A, Rhines LD, Versteeg AL, Sciubba DM, Lazary A, et al. Patient-reported and clinical outcomes of surgically treated patients with symptomatic spinal metastases: results from Epidemiology, Process, and outcomes of spine oncology (EPOSO), a prospective, multi-institutional and international study. Neurosurgery. 2024;95(5):1148\u201357. https:\/\/doi.org\/10.1227\/neu.0000000000002989.","journal-title":"Neurosurgery"},{"issue":"4","key":"1992_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.14245\/ns.1938402.201","volume":"16","author":"E Massaad","year":"2019","unstructured":"Massaad E, Fatima N, Hadzipasic M, Alvarez-Breckenridge C, Shankar GM, Shin JH. Predictive analytics in spine oncology research: first steps, limitations, and future directions. Neurospine. 2019;16(4):669\u201377. https:\/\/doi.org\/10.14245\/ns.1938402.201.","journal-title":"Neurospine"},{"issue":"5","key":"1992_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54(5):859\u201374. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.012.","journal-title":"Immunity"},{"key":"1992_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.omto.2023.07.008","volume":"30","author":"SN Paudel","year":"2023","unstructured":"Paudel SN, Hutzen B, Cripe TP. The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: is there hope? Mol Ther Oncolytics. 2023;30:227\u201337. https:\/\/doi.org\/10.1016\/j.omto.2023.07.008.","journal-title":"Mol Ther Oncolytics"},{"key":"1992_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194578","author":"A Resag","year":"2022","unstructured":"Resag A, Toffanin G, Bene\u0161ov\u00e1 I, M\u00fcller L, Potkrajcic V, Ozaniak A, et al. The immune contexture of liposarcoma and its clinical implications. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194578.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1992_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hep.32627","volume":"77","author":"KE Lindblad","year":"2023","unstructured":"Lindblad KE, Lujambio A. Imaging for better responses to immunotherapy in hepatocellular carcinoma. Hepatology. 2023;77(1):6\u20139. https:\/\/doi.org\/10.1002\/hep.32627.","journal-title":"Hepatology"},{"issue":"1","key":"1992_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13062-025-00645-8","volume":"20","author":"YY Shao","year":"2025","unstructured":"Shao YY, Wang HY, Hsu HW, Wo RR, Cheng AL, Hsu CH. Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma. Biol Direct. 2025;20(1):49. https:\/\/doi.org\/10.1186\/s13062-025-00645-8.","journal-title":"Biol Direct"},{"issue":"1","key":"1992_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-025-07789-5","volume":"16","author":"Y He","year":"2025","unstructured":"He Y, Liu D, Ling A, Han Z, Cui J, Cheng J, et al. Inhibition of Wnt\/\u03b2-catenin increases anti-tumor activity by synergizing with Sorafenib in hepatocellular carcinoma. Cell Death Dis. 2025;16(1):466. https:\/\/doi.org\/10.1038\/s41419-025-07789-5.","journal-title":"Cell Death Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01992-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:16:10Z","timestamp":1768342570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1992"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01992-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the the Medical Ethics Committee of Zhongshan Hospital, Fudan University (Approval No. B2024-540). Ethical approval for this study was granted with a waiver of patient consent by the Institutional Ethics Committee on the grounds that the research was retrospective and utilized pre-existing, de-identified data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"102"}}